Zinc oxide nanoparticles reduce the chemoresistance of gastric cancer by inhibiting autophagy

BACKGROUND: Gastric cancer (GC) is a common malignancy that results in a high rate of cancer-related mortality. Cisplatin (DDP)-based chemotherapy is the first-line clinical treatment for GC therapy, but chemotherapy resistance remains a severe clinical challenge. Zinc oxide nanoparticle (ZnO-NP) ha...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:World J Gastroenterol
Autores principales: Miao, You-Han, Mao, Li-Ping, Cai, Xiao-Juan, Mo, Xiao-Ying, Zhu, Qi-Qi, Yang, Fei-Tong, Wang, Mei-Hua
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Basic Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8291011/
https://ncbi.nlm.nih.gov/pubmed/34321849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v27.i25.3851
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares